Newsletter | October 17, 2025

10.17.25 -- What Are The Biggest Barriers To PAT Adoption?

SPONSOR

Biopharma supply, reimagined.

We’ve expanded our manufacturing footprint with a new filter manufacturing site in Blarney, Ireland. This new site complements our Jaffrey, USA site, and provides manufacturing redundancy for our best-in-class TFF, virus and sterilizing-grade filters. Committed to sustainability, this site operates on 100% renewable electricity, aiming for climate neutrality. Learn more or request a free filter sample today.

FOCUS ON SUPPLY CHAIN

Deep Interpretation Of GMP Product Quality

Explore the critical aspects of GMP-grade raw materials in cell and gene therapy manufacturing, including contamination control, aseptic strategies, quality systems, supply chain security, and regulatory compliance.

SUPPLY CHAIN SOLUTIONS

50-ML Stability Container Assembly For Frozen Storage - W.L. Gore & Associates

Blast Freezer For Pharmaceuticals: RoSS.BLST - Single Use Support

SPONSOR

Webinar: Optimizing DNA clearance in high-salt, GMP-grade purification processes

Join Qiagen’s webinar to explore advanced endonuclease technology for viral vector and biologics manufacturing. Learn how Saltonase® GMP-grade enables robust digestion in high-salt environments, breaking DNA down to 3–5 nucleotides. Discover how this next-generation approach overcomes limitations of conventional nucleases, ensures ≤10 ng residual DNA compliance, enhances purity, and drives more efficient, cost-effective cell and gene therapy processes. Click here to learn more.

FOCUS ON PROCESS ENGINEERING

What Are The Biggest Barriers To PAT Adoption?

In this segment from the Bioprocess Online Live event, “Aligning CMC And MSAT To Move PATs Out Of Pilot Mode,” our panelists discuss technology adoption and explain how risk aversion can impact PATs moving forward as a process matures.

Redefining Process Design And The Evolution Of Critical Process Parameters

Effectively managing process parameters and quality attributes is vital for successful drug development. Learn how a Quality by Design approach can optimize your processes and ensure product quality.

3 Key Considerations In Gene Therapy Manufacturing

Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.

Mastering QbD For Successful Process Validation Campaigns

In this presentation, industry-leading bioprocess experts explore the challenges and opportunities that arise when implementing Quality by Design (QbD) in biologics development and manufacturing.

Solid State Hydrogen Deuterium Exchange To Study ADC Stability

Discover how this solid-state HDX-MS is being used to revolutionize the prediction of stability for IgG-based Antibody Drug Conjugates and enhance ADC development processes.

How To Specify A Custom-Designed Instrument

Customers with a clear-eyed view of the solution’s basic specifications, budget, and expected timeline are well-positioned for an efficient, effective custom design experience.

PROCESS ENGINEERING SOLUTIONS

Solutions For Modern Labs To Advance Science And Healthcare - Tecan

GLP-1 Receptor Agonist Solutions - Waters Corporation

Accelerate Biologics Development With Electroporation Technology - MaxCyte, Inc.

SPONSOR

Webinar: Scaling Biologics: Strategies for Enhancing Bioprocessing Productivity in an Era of Therapeutic Innovation

Unlock the future of bioprocessing with this Ecolab webinar. As complex molecules transform biopharma, scaling efficiently while controlling purification costs is critical. Join industry leaders for an executive-level discussion on overcoming today’s manufacturing challenges, why “one size fits all” no longer works, and how innovative resin technologies and strategies accelerate your path from development to patients. Click here to learn more.

Connect With Bioprocess Online: